Natera, Inc. (NTRA) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

financial results conference call. At this time all participants are in a listen only mode. Following management's prepared remarks we will hold a question and answer session. To ask a question at that time please press star followed by one on your touchstone phone. If anyone has difficulty hearing the conference please press star zero for operator assistance. As a reminder this conference call is being recorded today August 7, 2025. I would now turn the conference call over to Michael Brophy, chief financial officer. Please go ahead. Thanks operator. Good afternoon. Thank you for joining our conference call to discuss the results of our second quarter of 2025. On the line I'm joined by Steve Chapman, our CEO, Salman Moshkovich, president, clinical diagnostics, and Al Coleshin, general manager of oncology and our chief medical officer. Today's conference call is being broadcast live via webcast. We will be referring to a slide that has been posted to .notera.com. A replay of the call will also be posted to our IR site as soon as it's available. Starting on slide two, during the course of this conference call we will make forward looking statements regarding future events and our anticipated future performance such as our operational financial outlook and projections, our assumptions for that outlook, market size partnerships, clinical studies, and expected results, opportunities and strategies, and expectations for various current and future products including product capabilities, expended release dates, reimbursement coverage, and related effects on our financial and operating results. We caution you that such statements reflect our best judgment based on factors currently known to us and that actual events or results could differ materially. Please refer to the do...